A 8502

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Passed Assembly Jan 23, 2024
  • Passed Senate Jan 29, 2024
  • Signed by Governor Feb 07, 2024

Requires health insurance policies and medicaid to cover biomarker precision medical testing for certain purposes

Abstract

Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.

Bill Sponsors (3)

Votes


Actions


Feb 07, 2024

Assembly

SIGNED CHAP.29

Assembly

DELIVERED TO GOVERNOR

Jan 29, 2024

Senate

SUBSTITUTED FOR S8040

Senate

RETURNED TO ASSEMBLY

Senate

PASSED SENATE

Senate

3RD READING CAL.40

Jan 23, 2024

Assembly

DELIVERED TO SENATE

Assembly

PASSED ASSEMBLY

Senate

REFERRED TO RULES

Jan 22, 2024

Assembly

ORDERED TO THIRD READING RULES CAL.4

Assembly

RULES REPORT CAL.4

Assembly

REPORTED

Assembly

REPORTED REFERRED TO RULES

Jan 08, 2024

Assembly

REPORTED REFERRED TO WAYS AND MEANS

Jan 04, 2024

Assembly

REFERRED TO INSURANCE

Bill Text

Bill Text Versions Format
A8502 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.